Background: Labour although a physiological process, is associated with severe, excruciating pain. The delivery of the infant into the arms of a conscious and a pain free mother is one of the most exciting and rewarding moments in medicine ……..Moir. Labour analgesia plays an important role in making the process of labour comfortable for the mother. Drugs like paracetamol and tramadol with advantages of easy availability, being inexpensive and with no special technique of administration are a boon for labour analgesia. Our study aims to evaluate the efficacy of these two drugs as labour analgesics.Methods: Sixty cases in active labour fulfilling inclusion and exclusion criteria were selected for this study. All primigravidae at term gestation with singleton pregnancy having vertex presentation with no associated obstetric/ medical/surgical risk factors in spontaneous labour were selected. There were thirty patients who received Paracetamol as labour analgesic and thirty were in the tramadol group. It was an observational study.Results: The study revealed that paracetamol had a significant analgesic effect compared to tramadol at the fourth and the fifth hour of administration. However, the overall analgesic effect of both the drugs had no statistically significant difference. Maternal side effects and neonatal distress were less with paracetamol.Conclusions: This study showed that paracetamol had a better side effect profile for both mother and neonate along with a comparable, if not better, analgesic effect vis a vis tramadol.
Background: India is the diabetic capital of the world and gestational diabetes mellitus contributes to a significant number of cases. Gestational diabetes mellitus is a common medical complication of pregnancy and may lead to serious consequences. Because of these reasons, it was felt that if there was a biomarker for predicting carbohydrate intolerance in pregnancy, it could help in earlier intervention and mitigate the consequences related to it. Hence, for this purpose, the role of HbA1c was studied as a predictor of gestational diabetes mellitus.Methods: This was a cross sectional study. Five hundred antenatal cases were considered for this study. All antenatal patients before 18 weeks of gestation attending antenatal clinic for the first time were selected and these patients were subjected to HbA1c followed by diabetes in pregnancy study group of India (DIPSI) test between 24-28 weeks and the results were analyzed to find any correlation between the two.Results: The main objective of the present study was to find whether HbA1c can be used as a predictor of gestational diabetes mellitus. In this study out of 500 women screened, 60 women turned out to have gestational diabetes mellitus. When comparing DIPSI positivity with various levels of HbA1c, it was found that maximum number of DIPSI positive patients (93.33%), had raised HbA1c levels.Conclusions: Maximum number of DIPSI positive cases had HbA1c level between 5.5 to 6 and this association was found to be statistically significant and a positive correlation was established between the two.
A 36-year primigravida presented at 16 weeks of gestation after a spontaneous conception for antenatal registration after primary infertility of 10 years. She had a history of myomectomy done by laparoscopy, 2 months before conception for a 10 cm posterior intra mural fibroid. At 33 weeks and 4 days of gestation, she had started leaking per vagina with left upper side abdominal pain. Her NST showed spontaneous decelerations and emergency LSCS was done. Intra operatively, there was hemoperitoneum due to uterine dehiscence at left cornua which was the previous myomectomy scar site. Baby was delivered and the lower segment uterine scar and dehiscence site were sutured in layers. The patient and baby recovered well.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.